ABOUT

Michael Sassano is the current CEO and Chairman of the Board for SOMAÍ Pharmaceuticals LTD, a large-scale manufacturer of cannabis products concentrating on the highest quality medical-grade pharmacological applications. We extract and purify bulk primary APIs of THC, THCa, CBD, CBN and other cannabinoids from the finest chosen cannabis flower. SOMAÍ’s proprietary formulations have multiple combinations of cannabinoid concentrations which can be delivered by gel capsules, drops, transdermal patches and other innovative delivery methods. All our products conform to the highest pharmaceutical standards and are produced with the latest technology to ensure consistency. Our team understands cannabis products and patient needs because of our vast experience on the west coast of USA, and we continue to research and develop the most innovative treatments for the World at our newest state-of-art Portuguese manufacturing facility.